JD(JD)
JD
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $1.37T | $1.45T | $1.53T | $1.61T |
| Low | $1.35T | $1.44T | $1.46T | $1.53T |
| High | $1.40T | $1.47T | $1.58T | $1.68T |
| EBITDA Avg | $37.25B | $39.51B | $41.49B | $43.80B |
| Low | $36.68B | $39.19B | $39.65B | $41.43B |
| High | $38.04B | $39.79B | $43.04B | $45.58B |
| EBIT Avg | $27.79B | $29.48B | $30.96B | $32.68B |
| Low | $27.37B | $29.24B | $29.58B | $30.91B |
| High | $28.38B | $29.69B | $32.11B | $34.00B |
| Net Income Avg | $33.11B | $44.04B | $52.81B | $49.20B |
| Low | $32.28B | $39.59B | $40.26B | $45.73B |
| High | $33.95B | $48.49B | $65.37B | $51.79B |
| EPS Avg | $22.03 | $28.87 | $35.18 | $33.04 |
| Low | $21.68 | $26.58 | $27.03 | $30.71 |
| High | $22.80 | $32.56 | $43.90 | $34.78 |
| Analysts (Rev / EPS) | 26 / 15 | 26 / 15 | 25 / 8 | 12 / 5 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $320.17B | $386.66B | $328.88B | $366.88B | $340.50B | $415.87B | $349.97B | $386.95B |
| Low | $319.68B | $379.97B | $323.19B | $360.53B | $334.60B | $408.67B | $343.91B | $380.25B |
| High | $320.65B | $397.04B | $337.71B | $376.73B | $349.64B | $427.03B | $359.37B | $397.34B |
| EBITDA Avg | $8.69B | $10.50B | $8.93B | $9.96B | $9.25B | $11.29B | $9.50B | $10.51B |
| Low | $8.68B | $10.32B | $8.78B | $9.79B | $9.09B | $11.10B | $9.34B | $10.33B |
| High | $8.71B | $10.78B | $9.17B | $10.23B | $9.49B | $11.60B | $9.76B | $10.79B |
| EBIT Avg | $6.49B | $7.83B | $6.66B | $7.43B | $6.90B | $8.43B | $7.09B | $7.84B |
| Low | $6.48B | $7.70B | $6.55B | $7.30B | $6.78B | $8.28B | $6.97B | $7.70B |
| High | $6.50B | $8.04B | $6.84B | $7.63B | $7.08B | $8.65B | $7.28B | $8.05B |
| Net Income Avg | $9.46B | $7.29B | $9.37B | $11.14B | $11.46B | $10.56B | $14.64B | $14.21B |
| Low | $9.24B | $7.13B | $9.16B | $10.89B | $11.20B | $10.32B | $14.32B | $13.89B |
| High | $9.79B | $7.55B | $9.69B | $11.53B | $11.86B | $10.93B | $15.16B | $14.71B |
| EPS Avg | $6.60 | $5.09 | $6.54 | $7.77 | $8.00 | $7.37 | $10.22 | $9.92 |
| Low | $6.45 | $4.98 | $6.39 | $7.60 | $7.82 | $7.21 | $9.99 | $9.70 |
| High | $6.83 | $5.27 | $6.77 | $8.05 | $8.28 | $7.63 | $10.58 | $10.27 |
| Analysts (Rev / EPS) | 8 / 7 | 6 / 2 | 4 / 2 | 5 / 2 | 4 / 2 | 6 / 2 | 3 / 3 | 4 / 5 |